FDA Nanotech Guidance Takes Small Step Forward
This article was originally published in The Tan Sheet
FDA initiates a dialogue with industry on nanotechnology in regulated products via a broad draft guidance document.
You may also be interested in...
FDA's draft guidance suggesting ingredients up to 1 micrometer in size that exhibit “altered properties” still qualify as nanomaterials should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.
FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.
FDA’s proposed warnings on spray sunscreen product labeling could open the door to tort litigation, according to Jennifer Quinn-Barabanov, an attorney specializing in product liability.